MedLife reaches €630 million pro-forma turnover in 2025 and continues investments in genomics, AI and personalized medicine

MedLife reaches €630 million pro-forma turnover in 2025 and continues investments in genomics, AI and personalized medicine

Mihai Marcu, CEO & President of the Board of Directors of MedLife Group:

“The economy is adjusting, and companies are feeling these changes. Consumption slowed down slightly, especially in the last quarter of 2025, but health remains a constant priority for Romanians. MedLife’s results remained solid, even in a challenging economic context. We believe that the recent measures are starting to take effect and the economy will return to a positive trend.

We look to the future with moderate optimism. The private sector continues to demonstrate its resilience: companies work, invest and actively contribute to the economy, even in difficult conditions.

MedLife remains one of the important pillars of the Romanian economy. The determination...